Department of Science and Technology (DST) Tender by Agharkar Research Institute (ari) (GEM/2025/B/6156372)
Nucleic Acid Sequencing and Genotyping Service - RNA Sequencing / Transcriptome Sequencing; Human;
Tender Timeline
Tender Title: Nucleic Acid Sequencing and Genotyping Service
Reference Number: GEM/2025/B/6156372
Issuing Authority/Department: Department of Science and Technology (DST), Ministry of Science and Technology
Scope of Work and Objectives
The Nucleic Acid Sequencing and Genotyping Service tender primarily focuses on RNA Sequencing and Transcriptome Sequencing services. The selected service provider will handle the collection of biological samples, which will predominantly comprise human samples, either directly from the buyer or from designated locales. The overarching objective is to deliver high-quality sequencing data to support scientific research and advancements in genomics.
Eligibility Criteria
To qualify for participation in this tender, bidders must be registered entities and possess relevant expertise in nucleic acid sequencing. Bidders should demonstrate a proven track record of providing similar services and must comply with any specific regulations stipulated by the Ministry of Science and Technology.
Technical Requirements
Bidders must meet stringent technical specifications including but not limited to:
- Capability to deliver sequencing data with a minimum accuracy of 90% or above.
- Use of high-throughput sequencing technologies, preferably the Illumina platform.
- Provision of raw data and primary analyses as part of the deliverables.
- Ability to handle a total quantity of 21 sequencing projects as outlined in the tender.
Financial Requirements
Potential bidders must ensure they comply with all financial stipulations outlined in the tender, which typically include presenting financial statements and proof of financial capacity to undertake the projects. Additionally, bidders need to be aware of any earnest money deposit (EMD) requirements, which are standard practice for such tenders.
Document Submission Details
Bidders are required to submit all the necessary documentation electronically through the designated government procurement portal. All proposals must include the requisite technical and financial documentation as evidence of their capabilities to fulfill the contract terms.
Special Provisions
This tender includes provisions for Micro, Small, and Medium Enterprises (MSEs) and startup entities, encouraging participation from smaller firms that contribute to the local economy and innovation as per the government's 'Make in India' initiative. MSEs may enjoy benefits regarding evaluation criteria and support to enhance competitiveness.
Evaluation Process
The evaluation process for this tender will include an assessment of technical competence, financial viability, and the overall proposed methodology to deliver sequencing services. The scoring will be based on predefined benchmarks focusing on quality, cost-effectiveness, and experience in delivering similar sequencing projects.
Delivery Locations
Delivery of services will occur at designated locations, as specified by the issuing authority. The selected firm will need to be flexible and capable of mobilizing resources to collect samples and conduct sequencing at the specified locations.
Contact Information
While specific contact details for inquiries are not provided in the documentation, bidders are encouraged to follow the submission guidelines and refer to the official government procurement website for further assistance.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements for this tender mandate that bidders must be registered entities with demonstrable expertise in the field of nucleic acid sequencing, specifically RNA sequencing services. Service providers should possess a history of managing similar projects effectively, complying with the standards outlined by the Ministry of Science and Technology. Additional qualifications may include possession of certifications relevant to genomic analytics and adherence to biosafety regulations. Bidders must also ensure they provide proof of capacity and capability to handle the expected volume of work associated with the total quantity of 21 sequencing projects as specified in the tender.
To comply with the tender’s participation criteria, bidders must submit relevant certifications demonstrating their technical capability and compliance with legal standards in the healthcare and genomic services sector. This typically includes quality management certifications such as ISO 9001, laboratory accreditations such as NABL, and any other certificates pertaining to safety and compliance in handling human samples. Providing evidence of past performance through client testimonials or project references will also be advantageous.
The evaluation and selection process for the Nucleic Acid Sequencing and Genotyping Service tender includes a comprehensive assessment of both the technical proposals and financial quotes submitted by bidders. Each submission will be evaluated based on a scoring matrix that considers quality, cost-effectiveness, experience, and proposed methodologies for sequencing work. A committee will evaluate the bids, and selected bidders will likely undergo further scrutiny to ensure compliance with the established technical specifications and quality standards. The results of the evaluation process will be communicated through official channels to all bidders involved in the tender.
Bidders participating in the Nucleic Acid Sequencing and Genotyping Service are often required to submit an Earnest Money Deposit (EMD) along with their proposals. The EMD serves as a financial guarantee that bidders will comply with the terms stipulated within the tender. The specific amount for the EMD will be outlined in the tender documentation. This deposit is typically refunded to the unsuccessful bidders after the selection process, while the selected bidder will have the EMD adjusted against performance security. It’s important for participants to confirm the exact amount and payment process when preparing their submissions.
MSEs participating in the Nucleic Acid Sequencing and Genotyping Service are provided with special considerations designed to increase their competitiveness in the bidding process. These benefits may include provisions that allow for lower qualifying requirements, simplified compliance procedures, and preferential treatment in evaluation. Additionally, this tender aligns with government initiatives like Make in India, encouraging MSEs to contribute to local content in procurement and enhancing the overall support framework for startups and smaller enterprises. Bidders are encouraged to showcase their commitment to local delivery and innovation to leverage these favorable provisions fully.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders